Cytoreductive Nephrectomy in the Current Treatment Algorithm

Therapeutic Advances in Medical Oncology - United States
doi 10.1177/1758835919879026
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

SAGE Publications

Related search

Trends in the Use of Cytoreductive Nephrectomy in the United States

Clinical Genitourinary Cancer
OncologyUrology
2012English

Cytoreductive Nephrectomy in the Era of Targeted Therapies: A Review

BJU International
Urology
2017English

Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Hypoalbuminaemia Is Associated With Mortality in Patients Undergoing Cytoreductive Nephrectomy

BJU International
Urology
2014English

Cytoreductive Nephrectomy in the Modern Era: Predictors of Use, Morbidity, and Survival

Canadian Urological Association Journal
Urology
2017English

Erratum to Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Complications Associated With Perioperative Use of Tyrosine Kinase Inhibitor in Cytoreductive Nephrectomy

Scientific Reports
Multidisciplinary
2019English

Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy in the United States: A SEER Analysis

World Journal of Urology
Urology
2012English

The Effect of Metastatic Focus on Survival After Cytoreductive Nephrectomy in Renal Cell Carcinoma: Experience of a Single Center

Acta Oncologica Turcica
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy